Skip to content
★ Sign in to follow
MW

Martin Welschof

CEO
BioInvent International AB (publ)BioInvent International AB
Total declarations
17
Companies
2
▲ Purchases (12 ops.)
€60k
▼ Sales (0 ops.)
—

Latest filing published 10 Mar 2022 for BioInvent International AB, €1,551.

Filing timeline

BuySale
Martin Welschof

Insider track record

Disclosed buys
12
Disclosed sells
0
Signal history

Closed purchases

Market purchases
12

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Martin Welschof: trading record in brief

Martin Welschof has filed trades across 2 companies (mainly through Finansinspektionen), most often in BioInvent International AB and BioInvent International AB (publ). In total, 17 filings cover trades dated from 24 April 2019 to 9 March 2022.

No open-market sale appears; the market trades are 12 purchases worth €60k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants. 2022 to date brings 10 purchases and no sales.

In size, the median ticket on the buying side is €1,749. Of 11 purchases, 1 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 10 March 2022, reports an open-market purchase of €1,551 in BioInvent International AB. The median gap between a trade and its publication by Finansinspektionen is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Martin Welschof

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ▲
    Verkställande direktör (VD)ExecutivesBioInvent International AB
    16,800 SEK22FI-SE
    500 shares@ SEK 33.602.6% of flowAktieISIN SE0015244520FI:csv-cd49cd9051edd04578aa
    Canonical exit: 7 Jun 2022 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesBioInvent International AB
    17,193 SEK22FI-SE
    530 shares@ SEK 32.442.6% of flowAktieISIN SE0015244520FI:csv-ca21bbbf8bb42ffa078c
    Canonical exit: 7 Jun 2022 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesBioInvent International AB
    109,799 SEK24FI-SE
    3,262 shares@ SEK 33.6616.7% of flowAktieISIN SE0015244520FI:csv-e8769306af95a6c2f029
    Canonical exit: 7 Jun 2022 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesBioInvent International AB
    6,740 SEK22FI-SE
    200 shares@ SEK 33.701.0% of flowAktieISIN SE0015244520FI:csv-7f07acec171f9af38336
    Canonical exit: 7 Jun 2022 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesBioInvent International AB
    20,701 SEK22FI-SE
    611 shares@ SEK 33.883.2% of flowAktieISIN SE0015244520FI:csv-d73d5dbe2e6745b17418
    Canonical exit: 7 Jun 2022 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesBioInvent International AB
    25,425 SEK22FI-SE
    750 shares@ SEK 33.903.9% of flowAktieISIN SE0015244520FI:csv-93cf6b748202a47d3239
    Canonical exit: 7 Jun 2022 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesBioInvent International AB
    27,200 SEK22FI-SE
    800 shares@ SEK 34.004.1% of flowAktieISIN SE0015244520FI:csv-8b4ea30f288982bd913a
    Canonical exit: 7 Jun 2022 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesBioInvent International AB
    612 SEK22FI-SE
    18 shares@ SEK 34.020.1% of flowAktieISIN SE0015244520FI:csv-01e8de8e60c32668af4c
    Canonical exit: 7 Jun 2022 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesBioInvent International AB
    11,206 SEK22FI-SE
    329 shares@ SEK 34.061.7% of flowAktieISIN SE0015244520FI:csv-e9219e700b66467198b5
    Canonical exit: 7 Jun 2022 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesBioInvent International AB
    13,712 SEK22FI-SE
    400 shares@ SEK 34.282.1% of flowAktieISIN SE0015244520FI:csv-90db62a27f49db2418ab
    Canonical exit: 7 Jun 2022 (T+90)
  • ◆
    Verkställande direktör (VD)ExecutivesBioInvent International AB
    0FI-SE
    295,492 shares0OptionFI:csv-6edaba7c6f41c7ad3379
  • ▲
    Verkställande direktör (VD)ExecutivesBioInvent International AB
    188,842 SEK40FI-SE
    5,000 shares@ SEK 37.768430.6% of flowAktieISIN SE0000789711FI:csv-eeddafe4c79251ea433c
    Canonical exit: 19 Dec 2021 (T+90)
  • ◆
    Verkställande direktör (VD)ExecutivesBioInvent International AB (publ)
    159,566 SEK0FI-SE
    295,492 shares@ SEK 0.5448.6% of flowOptionFI:csv-c26928693f496579d6b2
  • ●
    Managing DirectorExecutivesBioInvent International AB (publ)
    0FI-SE
    14 shares0TeckningsrättISIN SE0014684478FI:csv-4f13d79420261d3f2dfa
  • ●
    Managing DirectorExecutivesBioInvent International AB
    0FI-SE
    227,900 shares0TeckningsrättISIN SE0014684478FI:csv-d811d311acfd1d72acaf
  • ●
    VDExecutivesBioInvent International AB
    200,000 SEK0FI-SE
    125,000 shares@ SEK 1.60100.0% of flowBTA (betald tecknad aktie)ISIN SE0012453769FI:csv-eef31c0a7ffcf74c5053

16 of 16 declarations